PSA elevat: diferència entre les revisions

Línia 166: Línia 166:
Mireia: <cite>2007JNCI,2006coc,2007bju,2006urol,2002ptt,2006aeu1,2006bju,2003jafp,2006ui,2000jgim,2006oncol</cite>
Mireia: <cite>2007JNCI,2006coc,2007bju,2006urol,2002ptt,2006aeu1,2006bju,2003jafp,2006ui,2000jgim,2006oncol</cite>


Laia:  
Laia:
<cite>2004FMC,2007uti,2001atpr,2007bmj,2007afp,2007afp1,2006bmj,2003bmj,2003afp,2002cmaj,2006clch,2007nejm,2007cmaj,2007mcp,2007bjui,2004bju,2002can,NICE1</cite>
 
Laia creu no aprofitables: <cite>2006clev,2003clev,2005wimj</cite>
 
Laia no ha trobat a ics: <cite>,hhh,1999fampract,2006safr,2007rrcr,2007urol,2007urol1,2004urol,2001urol,2004aim,2004ccc,2008bju,2007ju1,2007ju,2007clt,2007cl,2007p</cite>
 


<biblio>
<biblio>
Línia 213: Línia 219:
#2004bju pmid=14678366
#2004bju pmid=14678366
#2002can pmid=12365027
#2002can pmid=12365027
#NICE1 Guidance for Commissioning Cancer Services Improving Outcomes in Urological Cancers
#NICE1 Guidance for ...Outcomes in Urological The Research Evidence NICE
The Research Evidence NICE
#NICE2 Improving outcomes in urological cancers - Manual NICE
# Clinical clinical evidence
#2006oncol pmid=16601365
#2006oncol pmid=16601365
#2006bju pmid=16566811  
#2006bju pmid=16566811  
Usuari anònim